C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase a activation

Circulation

Volumn 128, Issue SUPPL.1, 2013, Pages

  Sun, Yang ^a,b   Yi, Wei ^a,b   Yuan, Yuexing ^b   Lau, Wayne Bond ^b   Yi, Dinghua ^a   Wang, Xiaoliang ^b   Wang, Yajing ^a,b   Su, Hui ^b   Wang, Xiaoming ^a   Gao, Erhe ^c   Koch, Walter J ^c   Ma, Xin Liang ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipokines; Apoptosis; Cardiac remodeling; Myocardial infarction

Indexed keywords

C1 Q TUMOR NECROSIS FACTOR RELATED PROTEIN 9; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN KINASE B; RECOMBINANT TUMOR NECROSIS FACTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CORONARY ARTERY LIGATION; DRUG MECHANISM; FIBROSIS; HEART FUNCTION; HEART MUSCLE CELL; HEART PROTECTION; IN VITRO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SHAM PROCEDURE; SURVIVAL RATE;

ADIPOKINES; APOPTOSIS; CARDIAC REMODELING; MYOCARDIAL INFARCTION;

ADIPOCYTES; ADIPOKINES; ADIPONECTIN; ANIMALS; CARDIOTONIC AGENTS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOKINES; ENZYME ACTIVATION; GLYCOPROTEINS; INFUSION PUMPS, IMPLANTABLE; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL ISCHEMIA; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84883825935     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.000010     Document Type: Article

References (19)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation. 2011;123:e18-e209.
2. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35:569-582.
3. Schram K, Sweeney G. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure. Trends Cardiovasc Med. 2008;18:199-205.
4. Wong GW, Wang J, Hug C, Tsao TS, Lodish HF. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci U S A. 2004;101:10302-10307.
5. Wei Z, Peterson JM, Wong GW. Metabolic regulation by C1q/TNFrelated protein-13 (CTRP13): Activation OF AMP-activated protein kinase and suppression of fatty acid-induced JNK signaling. J Biol Chem. 2011;286:15652-15665.
6. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Ge G, Spooner E, Hug C, Gimeno R, Lodish HF. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J. 2009;23:241-258.
7. Zheng Q, Yuan Y, Yi W, Lau WB, Wang Y, Wang X, Sun Y, Lopez BL, Christopher TA, Peterson JM, Wong GW, Yu S, Yi D, Ma XL. C1q/TNFrelated proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway. Arterioscler Thromb Vasc Biol. 2011;31:2616-2623.
8. Kambara T, Ohashi K, Shibata R, Ogura Y, Maruyama S, Enomoto T, Uemura Y, Shimizu Y, Yuasa D, Matsuo K, Miyabe M, Kataoka Y, Murohara T, Ouchi N. CTRP9 protects against myocardial injury following ischemia-reperfusion through AMPK-dependent mechanism. J Biol Chem2012;287:18965-18973.
9. Yuan YX, Gao E, Wang YJ, Wang XL, Yi W, Lau WB, Wong GW, Koch WJ, Ma XL. CTRPs, a novel therapeutic target against myocardial ischemia/reperfusion injury. Circulation.2010;122:A14133.
10. Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, Fan Q, Chuprun JK, Ma XL, Koch WJ. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res. 2010;107:1445-1453.
11. Yi W, Sun Y, Gao E, Wei X, Lau WB, Zheng Q, Wang Y, Yuan Y, Wang X, Tao L, Li R, Koch W, Ma XL. Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms. Antioxid Redox Signal. 2011;15:1779-1788.
12. Tao L, Gao E, Bryan NS, Qu Y, Liu HR, Hu A, Christopher TA, Lopez BL, Yodoi J, Koch WJ, Feelisch M, Ma XL. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: Role of S-nitrosation. PNAS 2004;101:11471-11476.
13. Ouchi N, Shibata R, Walsh K. Targeting adiponectin for cardioprotection. Expert Opin Ther Targets. 2006;10:573-581.
14. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004;10:1384-1389.
15. Xing Y, Musi N, Fujii N, Zou L, Luptak I, Hirshman MF, Goodyear LJ, Tian R. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J Biol Chem. 2003;278:28372-28377.
16. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB, Greenberg M.E. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell. 2000;6:41-51.
17. Park MK, Kang YJ, Ha YM, Jeong JJ, Kim HJ, Seo HG, Lee JH, Chang KC. EP2 receptor activation by prostaglandin E2 leads to induction of HO-1 via PKA and PI3K pathways in C6 cells. Biochem Biophys Res Commun. 2009;379:1043-1047.
18. Tan Y, Demeter MR, Ruan H, Comb MJ. BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J Biol Chem. 2000;275:25865-25869.
19. Lizcano JM, Morrice N, Cohen P. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J. 2000;349(pt 2):547-557.